FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Bliss GVS Pharma LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:506197 P/E (TTM) :28.24
ISIN Demat:INE416D01022 Div & Yield %:0.24 EPS (TTM) :7.34
Book Value (RS) :104.3299482 Market Cap (Rs Cr.):2193.01 Face Value (RS) :1
    Change Company 
Particulars Quarter Ended
(Dec 2025)		 Quarter Ended
(Dec 2024)		 Quarter Ended
(% Var)
Sales 164.68 179.59 -8.30
Other Income 10.23 11.66 -12.26
PBIDT 34.57 37.40 -7.57
Interest 1.48 0.67 120.90
PBDT 33.09 36.73 -9.91
Depreciation 7.80 6.96 12.07
PBT 25.29 29.77 -15.05
Tax 7.52 10.27 -26.78
Deferred Tax -0.84 -1.55 0.00
PAT 18.61 21.05 -11.59

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)